Billionaires are investing heavily in a cutting-edge tech company specializing in the creation of genetically engineered monkey organs, with hopes that lab-grown human parts could soon follow.

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...

In April 2025, the US Food and Drug Administration (FDA) announced plans to phase out certain animal testing requirements, ...

In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...

Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body. Led by ...

Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come far enough to replace animal research? Additionally, despite attempts to ...

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...